This article is part of the supplement: Targeting B cells in autoimmune diseases
Review
Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
Arthritis Res Ther 2003, 5(Suppl 4):S12-S16 doi:10.1186/ar1008
Accesses
- Last 30 days: 41 accesses
- Last 365 days: 493 accesses
- All time: 9947 accesses

